Sinopharm
1099.HK
#2016
Rank
S$10.40 B
Marketcap
$3.34
Share price
1.04%
Change (1 day)
-11.53%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): S$3.28 Billion

According to Sinopharm's latest financial reports the company's current earnings are S$84.39 Billion. a decrease over its 2022 earnings that were of S$4.26 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 S$4.23 B-0.73%
2022 S$4.26 B-1.72%
2021S$4.33 B11.7%
2020S$3.88 B18.44%
2019S$3.28 B10.85%
2018S$2.95 B3.05%
2017S$2.87 B36.48%
2016S$2.10 B7.11%
2015S$1.96 B12.38%
2014S$1.74 B25.05%
2013S$1.39 B22.54%
2012S$1.14 B35.43%
2011S$0.84 B52.24%
2010S$0.55 B30.99%
2009S$0.42 B60.59%
2008S$0.26 B48.29%
2007S$0.17 B123.29%
2006S$79.43 M